iRhythm completes VitalConnect acquisition for $237.5 million cash, issues up to 423,334 shares

Bitget2026/10/05 13:13

iRhythm completed its acquisition of VitalConnect, adding wearable biosensors, mobile cardiac telemetry, and multi-vitals monitoring across ambulatory and inpatient settings. Purchase consideration included USD 237.5 million cash, up to 423,334 shares at closing, and USD 10 million of working-capital funding pre-close. Deal expected to expand iRhythm’s addressable market into hospital-to-home care, leveraging its health system relationships and integrated clinical services. Transaction expected to lift revenue growth beginning in 2027 while maintaining a 15% adjusted EBITDA margin target for 2027. Updated 2026 guidance including VitalConnect is planned for the third-quarter earnings call on Nov. 5, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. iRhythm Technologies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610050905PRIMZONEFULLFEED9839527) on October 05, 2026, and is solely responsible for the information contained therein.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

iRhythm completed its acquisition of VitalConnect, adding wearable biosensors, mobile cardiac telemetry, and multi-vitals monitoring across ambulatory and inpatient settings.
Purchase consideration included USD 237.5 million cash, up to 423,334 shares at closing, and USD 10 million of working-capital funding pre-close.
Deal expected to expand iRhythm’s addressable market into hospital-to-home care, leveraging its health system relationships and integrated clinical services.
Transaction expected to lift revenue growth beginning in 2027 while maintaining a 15% adjusted EBITDA margin target for 2027.
Updated 2026 guidance including VitalConnect is planned for the third-quarter earnings call on Nov. 5, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. iRhythm Technologies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610050905PRIMZONEFULLFEED9839527) on October 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

A new twist has emerged in the US AI data center investment boom. SoftBank is preparing for cooling US demand and a deteriorating political environment, and does not rule out shifting data center construction priorities to other countries. As cross-border computing power delivery capability improves and investment returns come under question, the logic behind AI infrastructure expansion is loosening, and over $3.5 trillion in infrastructure investment now faces potential impairment risks.

华尔街见闻•2026/11/09 10:26